The analysis of co-expression of the surface markers CD39 and CD73 on B220+ cells in the spleen on days 7, 14 and 21 showed a significant, continuous increase in the expression of these ectonucleoside triphosphatase/diphosphohydrolases in the tumor group compared to the control group. The gene discussed is ENTPD1; the disease is neoplasm.